← Leaderboards
Xuewei Zhu
Wake Forest University Health Sciences
$2,449,195
Attributed
$2,449,195
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $370.4K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,449,195 · 2
By mechanism
R01$1,851,885 · 1
R41$597,310 · 1
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Vidula Vachharajani$6,649,049
- Carol A. Shively$17,339,095
- Liwu Li$14,159,772
- Timothy Sebastian Pardee$4,288,289
- Nilamadhab Mishra$2,347,341
Others in their field
Top investigators on “Attenuated”
- Lawrence Corey · Fred Hutchinson Cancer Center$124,686,255
- Stephen Lev Hoffman · Sanaria, Inc.$61,062,195
- Robert M. Grant · J. David Gladstone Institutes$48,731,024
- Jerri Edwards · University Of South Florida$42,327,407
- John C S Breitner · Johns Hopkins University$38,118,097
- Michael W Weiner · Northern California Institute Res &Educ$36,929,917
Research focus
AttenuatedInflammationToll-Like ReceptorsPlayNovel TherapeuticsInflammatoryMaleMacrophageMolecularPlasmaBone MarrowPathway InteractionsMetabolicMediatingGlycolysisAcuteAtherosclerosisAtherogenic DietEnergy-Generating ResourcesAtherogenesisArterial Fatty StreakAdipose TissueFamilyBlood Glucose Regulation
Grant awards (7)
Targeting macrophage maladaptation for bacterial sepsis treatment$297,328
R41 · FY2024 · AI · contact PI
Targeting macrophage maladaptation for bacterial sepsis treatment$299,982
R41 · FY2023 · AI · contact PI
The role of SLC37A2, a glucose 6 phosphate transporter, in inflammation and metabolic diseases$370,377
R01 · FY2020 · HL · contact PI
The role of SLC37A2, a glucose 6 phosphate transporter, in inflammation and metabolic diseases$370,377
R01 · FY2019 · HL · contact PI
The role of SLC37A2, a glucose 6 phosphate transporter, in inflammation and metabolic diseases$370,377
R01 · FY2018 · HL · contact PI
The role of SLC37A2, a glucose 6 phosphate transporter, in inflammation and metabolic diseases$370,377
R01 · FY2017 · HL · contact PI
The role of SLC37A2, a glucose 6 phosphate transporter, in inflammation and metabolic diseases$370,377
R01 · FY2016 · HL · contact PI